<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Pediatric Ophthalmology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Pediatric Ophthalmology</journal-title><trans-title-group xml:lang="ru"><trans-title>Российская педиатрическая офтальмология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1993-1859</issn><issn publication-format="electronic">2412-432X</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">37659</article-id><article-id pub-id-type="doi">10.17816/rpoj37659</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The role of the systemic disbalance of serum cytokine levels in pathogenesis of retinopathy of prematurity</article-title><trans-title-group xml:lang="ru"><trans-title>Роль системного дисбаланса цитокинов в патогенезе ретинопатии недоношенных</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Katargina</surname><given-names>L. A</given-names></name><name xml:lang="ru"><surname>Катаргина</surname><given-names>Л. А</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Slepova</surname><given-names>O. S</given-names></name><name xml:lang="ru"><surname>Слепова</surname><given-names>О. С</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Demchenko</surname><given-names>E. N</given-names></name><name xml:lang="ru"><surname>Демченко</surname><given-names>Е. Н</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Osipova</surname><given-names>Natal'ya Anatol’evna</given-names></name><name xml:lang="ru"><surname>Осипова</surname><given-names>Наталья Анатольевна</given-names></name></name-alternatives><email>natashamma@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">The Helmholtz Moscow Research Institute of Eye Diseases</institution></aff><aff><institution xml:lang="ru">ФГБУ «Московский НИИ глазных болезней им. Гельмгольца» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2015-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2015</year></pub-date><volume>10</volume><issue>4</issue><issue-title xml:lang="en">VOL 10, NO4 (2015)</issue-title><issue-title xml:lang="ru">ТОМ 10, №4 (2015)</issue-title><fpage>16</fpage><lpage>19</lpage><history><date date-type="received" iso-8601-date="2020-07-21"><day>21</day><month>07</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2015, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2015, ООО "Эко-Вектор"</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">ООО "Эко-Вектор"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://ruspoj.com/1993-1859/article/view/37659">https://ruspoj.com/1993-1859/article/view/37659</self-uri><abstract xml:lang="en"><p>The present study of the systemic disbalance of the serum cytokine levels included 80 prematurely born children before they developed clinical manifestations of retinopathy of prematurity (ROP). The analysis of the relationship between the characteristics of the cytokine status and the development of ROPduring the subsequent period was undertaken. It was shown that the frequency of detection of cytokines and their concentration in the blood serumof the premature infants are subject to broad variations. The study revealed the tendency toward the prevalence of potentially “pathogenic” (angiogenic, proinflammatory) cytokines in the sera of the premature children who later developed the “threshold” stage of ROPwhich dictated the necessity of laser coagulation of the avascular retinal regions. Of special interest are the observations of serum IGF-II and TGF-beta levels. The former of these parameters showed the fairly well-apparent tendency toward increase in the group of the children with the “threshold” stage of ROP while the letter tended to decrease. It is concluded that the further investigations into the relationship ofserum IGF-II and TGF-beta levelswith those of VEGF at different stages of ROP evolution have good prospects.</p></abstract><trans-abstract xml:lang="ru"><p>Проведены исследование системного цитокинового статуса недоношенных детей до клинической манифестации ретинопатии недоношенных и анализ взаимосвязи дисбаланса его показателей с дальнейшим развитием и характером течения заболевания. Показано, что частота выявления цитокинов и диапазон значений их концентрации в сыворотке крови недоношенных детей широко варьирует. Выявлена тенденция к превалированию условно «патогенных» цитокинов (ангиогенных, провоспалительных) в сыворотке крови детей с развившейся впоследствии «пороговой» стадией ретинопатии недоношенных, потребовавшей проведения лазеркоагуляции аваскулярных зон сетчатки. Особый интерес представили данные, полученные в отношении уровня IGF-II и TGF-β в сыворотке крови детей, для первого из которых выявлялась четкая тенденция к повышению концентрации в группе детей с “пороговой” ретинопатией недоношенных, а для второго - к снижению. Перспективным является изучение их взаимодействия с VEGF в разные фазы развития ретинопатии недоношенных.</p></trans-abstract><kwd-group xml:lang="en"><kwd>retinopathy of prematurity</kwd><kwd>pathogenesis</kwd><kwd>prognosis</kwd><kwd>immunological studies</kwd><kwd>cytokines</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>ретинопатия недоношенных</kwd><kwd>патогенез</kwd><kwd>прогнозирование</kwd><kwd>иммунологическое обследование</kwd><kwd>цитокины</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Phelps D.L. Retinopathy of prematurity. Pediatr. Clin. N. Am. 2004; 40: 705-14.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>O’Conner M.T., Vohr B.R., Tucker R., Cashore W. Is retinopathy of prematurity increasing among infants less than 1250 g birth weight? J. Perinatol. 2003; 23: 673-8.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Sood B.G., Madan A., Saha Sh., Schendel D., Thorsen P., Skogstrand K. et al. Perinatal systemic inflammatory response syndrome and retinopathy of prematurity. Pediatr. Res. 2010; 67 (4): 394-400.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Silveira R.C., Fortes Filho J.B., Procianoy R.S. Assessment of the contribution of cytokine plasma levels to detect retinopathy of prematurity in very low birth weight infants. Invest. Ophthalmol. Vis. Sci. 2011; 52 (3): 1297-301.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Villegas-Becerril E., González-Fernández R., Perula-Torres L., Gallardo-Galera J.M. IGF-I, VEGF and bFGF as predictive factors for the onset of retinopathy of prematurity (ROP). Arch. Soc. Esp. Oftalmol. 2006; 81 (11): 641-6.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Катаргина Л.А., Слепова О.С., Скрипец П.П., Дементьева Г.М. Гуморальный иммунный ответ на S-антиген сетчатки у недоношенных детей с ретинопатией недоношенных. Вестник офтальмологии. 2003; 1: 20-2.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Smith L.E.H. Pathogenesis of retinopathy of prematurity. Semin. Neonatol. 2003; 8: 469-73.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Федеральные клинические рекомендации «Диагностика, мониторинг и лечение активной фазы ретинопатии недоношенных» (Национальный протокол). Российская педиатрическая офтальмология. 2015; 1: 54-61.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Yalin Imamoglu E., Gunay M., Gursoy T., Imamoglu S., Balci Ekmekci O., Celik G. et al. Effect of laser photocoagulation on plasma levels of VEGF-A, VEGFR-2, and Tie2 in infants with retinopathy of prematurity. J. AAPOS. 2014; 18 (5): 466-70.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Hellstrom A., Engstrom E., Hard A.-L. et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics. 2003; 112: 1016-20.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Hellstrom A., Perruzzi C., Ju M. et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc. Natl. Acad. Sci. USA. 2001; 98: 5804-8.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Castellon R., Hamdi H.K., Sacerio I., Aoki A.M., Kenney M.C., Ljubimov A.V. Effects of angiogenic growth factor combinations on retinal endothelial cells. Exp. Eye. Res. 2002; 74: 523-35.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Wahl S.M. Transforming growth factor-beta: innately bipolar. Curr. Opin. Immunol. 2007; 19: 55-62.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Qiao H., Sonoda K.H., Ikeda Y., Yoshimura T., Hijioka K., Jo Y.J. et al. Interleukin-18 regulates pathological intraocular neovascularization. J. Leukoc. Biol. 2007; 81: 1012-21.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Altinova A.E., Yetkin I., Akbay E., Bukan N., Arslan M. Serum IL-18 levels in patients with type 1 diabetes: relations to metabolic control and microvascular complications. Cytokine. 2008; 42: 217-21.</mixed-citation></ref></ref-list></back></article>
